human CYP1B1, a new member of the cytochrome P450 superfamily. Here, we report on the mapping and function of the CYP1B1 promoter. The CYP1B1 promoter is fully functional, when it is uncoupled from upstream enhancer elements. Deletion analysis and site-directed mutagenesis identified four regulatory elements required for maximum promoter activity: two antisense Sp1 sites (؊84 to ؊89 and ؊68 to ؊73), a TATA-like box (؊34 to ؊29), and an initiator motif (؊5 to ؉3). The initiator and the TATA-like elements are both required for basal promoter activity, with enhanced activity mediated by the two antisense Sp1 elements. The CYP1B1 initiator was demonstrated by in vitro transcription analysis to be a positioning element that maintained fidelity of transcription from a single site. Specific binding to a CYP1B1 initiator probe by human nuclear extract proteins was competed either by the highly homologous murine terminal deoxynucleotidyl transferase initiator or, to a lesser extent, by the adenovirus major late initiator. Taken together, these results indicate that the structure and function of the CYP1B1 promoter confers constitutive expression of the gene and assures fidelity of transcription initiation from a single site. The CYP1B1 promoter is distinct from the promoters of the closely related cytochrome P450s CYP1A1 and CYP1A2 and is structurally and functionally similar to the promoters of constitutively expressed genes and at least two viruses.
only known member of a new cytochrome P450 subfamily, CYP1B (2) . Orthologous cDNAs have been identified and cloned from tissues from the mouse (3, 4) and rat (5, 6) . A human genomic clone for CYP1B1 recently has been isolated and characterized by our laboratory (7) . Comparison of the genes for CYP1B1 with the other two members of the CYP1 family, CYP1A1 and CYP1A2, reveal several features that distinguish the CYP1B1 gene: (i) presence of only three exons versus seven (8) , (ii) location on human chromosome 2 versus 15 (9, 10) , and (iii) absence of a canonical TATA box, CCAAT motif, and basal transcription element (11) (12) (13) .
CYP1B1 mRNA is expressed constitutively in several organs, including the adrenal glands, ovaries, prostate, and testes, and is inducible by planar aromatic hydrocarbons, adrenocorticotrophin, and other peptide hormones (2, 14, 15) . In contrast, CYP1A1 is not expressed constitutively; however, induced CYP1A1 mRNA and protein can be detected in human liver (16) . The differential expression of constitutive CYP1A1 and CYP1B1 presumably is modulated by cis-acting regulatory elements located within or near to their respective promoters. In this regard, the CYP1A1 and CYP1A2 promoters have been shown to be silent when uncoupled from upstream enhancer elements (17, 18) .
Here, we present the mapping and characterization of functional modalities within the CYP1B1 promoter region. The CYP1B1 promoter consists of at least four distinct regulatory elements. All are required for maximum promoter activity and are functional, when uncoupled from upstream enhancers. An 8-bp sequence surrounding the transcription start site was found to bind to sequence-specific DNA-binding proteins present in SCC12(c12c2) nuclear extracts and to function as a positioning element, assuring the fidelity of transcription from the single initiation site (TIS), identified previously (7) .
EXPERIMENTAL PROCEDURES
Human CYP1B1 Gene Promoter Constructs-Heterologous chloramphenicol acetyltransferase (CAT) reporter gene constructs containing progressive deletions of the CYP1B1 gene 5Ј-flanking region were made as described previously (7) . 5Ј-End deletions of the Ϫ164/ϩ25 fragment in the pCATbasic(Ϫ164/ϩ25) vector were made as follows: three oligonucleotides (20-mers) , each containing a 5Ј-end HindIII site, and a vector-specific primer (spanning sequence from nt 2803 to nt 2783 in pCAT-Basic) were used for polymerase chain reaction (PCR) to amplify the fragments containing the CYP1B1 sequence Ϫ101 to ϩ25, Ϫ83 to ϩ25, or Ϫ47 to ϩ25, plus 540 base pairs of CAT gene sequence. These PCR products were digested with HindIII and BalI, and cloned into the HindIII/BalI-digested pCAT-Basic vector to generate the constructs pCATbasic(Ϫ101/ϩ25), pCATbasic(Ϫ83/ϩ25), and pCATbasic(Ϫ47/ ϩ25). Constructs containing part of exon 1 (pCATbasic(Ϫ164/ϩ184)) and the entire exon 1 and intron 1 (pCATbasic(Ϫ164/ϩ761)) of the CYP1B1 gene were made using the same approach. * This work was supported by grants from the American Forest and Paper Association, the General Electric Company, and the Public Health Service (ES07009). A preliminary account of this research was presented at the 34th Annual Meeting of the Society of Toxicology, Baltimore, MD, March 5-9, 1995. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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Site-directed Mutagenesis-Mutations in the CYP1B1 promoter were created by oligonucleotide-directed PCR mutagenesis as described previously (19) . By using four primers (two vector-specific primers and two complementary mutagenic primers) and two-step PCR, three CYP1B1 promoter regulatory elements in the construct pCATbasic(Ϫ164/ϩ25) were individually mutated to specific restriction sites. Two antisense GC boxes (i.e. GGGCGG, start from nt Ϫ84 and nt Ϫ68), which presumably could bind to the transcription factor Sp1, were altered to SalI sites. In contrast, the TATA-like sequence (i.e. TTAAAA, from nt Ϫ33 to nt Ϫ28) and the sequence surrounding the transcription start site (i.e. Ϫ3 TTGACTCT ϩ5) were mutated to PstI and XbaI sites, respectively. Double mutations on both Sp1 recognition motifs were constructed exactly as described above, except that the template used in the PCR was derived from a mutant promoter that already contained a single Sp1 site mutation. All of the CAT reporter constructs were sequenced (20) and subjected to restriction analysis to confirm that the desired mutation was present and that no other alterations had occurred.
Transfection and CAT Assay-The procedures for transient transfection of SCC12(c12c2) cells and assay of CAT gene activity were as described previously (8) . The analysis of each construct was done on at least three sample dishes and was repeated at least twice.
Nuclear Extract and Gel Mobility Shift Assay-Nuclear extracts for gel shift assay were prepared from SCC12(c12c2) cells according to the method described (21) , dialyzed against buffer D (20 mM Hepes (pH 7.8), 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), and 20% glycerol), and stored in small aliquots at Ϫ80°C. Protein concentration was determined as described (22) , using bovine serum albumin as a standard.
Two DNA probes were used for gel shift analysis. One was a PCRamplified DNA fragment (spanning the sequence from Ϫ101 to Ϫ43) in which two consensus Sp1 binding motifs were encompassed. The PCR product, which was incorporated with HindIII and XbaI sites at its 5Ј-ends, was digested with HindIII and XbaI, filled in with [␣-32 P]dATP, and purified by polyacrylamide gel electrophoresis. For mobility shift assay, 5 g of nuclear protein (or 20 ng of purified Sp1 protein (Promega)) was preincubated at room temperature in a reaction solution (15 l) containing 10 mM Hepes-NaOH (pH 7.9), 0.1 mM EDTA, 50 mM KCl, 0.25 mM DTT, 0.25 mM PMSF, 1 mM MgCl 2 , 10% glycerol, and 1 g of poly(dI⅐dC)⅐poly(dI⅐dC) (Pharmacia Biotech Inc.). The probe (10,000 cpm) was then added, and the incubation was continued for another 15 min. The samples were analyzed at 4°C on a 5% nondenaturing polyacrylamide gel (30:1 acrylamide:bisacrylamide), containing 6.7 mM Tris-HCl (pH 7.9), 3.3 mM sodium acetate, and 1 mM EDTA.
The other probe was made to examine the sequence surrounding the TIS of the CYP1B1. A pair of synthetic complementary oligonucleotides (5Ј-GCGCGCTTTGACTCTGGAGT-3Ј and 5Ј-GACTCCAGAGTCAAAG-CGCG-3Ј), which correspond to the sequence from Ϫ10 to ϩ11 relative to the transcription start site, were prepared and annealed as described (23) . The annealed double-stranded oligonucleotide was labeled with [␣-32 P]dCTP and Klenow fragment (Life Technologies, Inc.) and subsequently purified by PAGE. The experimental procedure for the gel shift assay was similar to that described above, except using 10 g of nuclear protein, 2 g of poly(dI⅐dC)⅐poly(dI⅐dC), 20,000 cpm of probe, and a modified buffer containing 10 mM Hepes-NaOH (pH 7.9), 60 mM KCl, 1 mM EDTA, 1 mM DTT, 10% glycerol, and 1 mM PMSF.
Competition studies were performed, to analyze the binding specificity, by using 100 -400-fold molar excess of the unlabeled initiator sequences from TdT, the adenovirus major late promoter (AdML), or the mutated CYP1B1 Inr shown below (Sequences 1-3). The competitor was added immediately before the addition of radiolabeled probe. In Vitro Transcription Analysis-In vitro transcription reactions were conducted on 550-bp PvuII/PvuII fragments obtained from the heterologous CAT reporter construct pCATbasic(Ϫ164/ϩ25) and constructs containing mutations at either or both Sp1 sites, the TATA-like sequence, and the Inr (see above), using a HeLa cell nuclear extract in vitro transcription system (Promega). Briefly, a reaction mixture (23.5 l total) containing 100 ng of DNA fragment, 8 units of HeLa nuclear extract, 40 units of RNasin (Promega), 6 mM MgCl 2 , 3 mM Hepes (pH 7.9), 44 mM KCl, 0.1 mM EDTA, and 0.2 mM DTT was preincubated for 15 min at room temperature. After this period, an aliquot of 1.5 l of ribonucleotide mix (10 mM each of rNTP) was added, and the reaction mixture was further incubated at room temperature for another 15 min. The reaction was terminated by adding 175 l of the stop mix (containing 0.3 M Tris-HCl (pH 7.4), 0.3 M sodium acetate, 0.5% SDS, 2 mM EDTA, and 3 g/ml tRNA). After the extraction with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1), the synthesized RNA was precipitated with 95% ethanol, centrifuged, and dried.
The RNA transcribed in vitro was subsequently analyzed by primer extension reaction. The primer used for the reaction was a 34-mer oligonucleotide (5Ј-CTCCTGAAAATCTCGCCAAGCTCAGATCCTCTA-G-3Ј), which is complementary to the 5Ј-end of the CAT reporter gene. Primer extension was started by dissolving the RNA in a 10-l buffer solution containing 10 mM Tris-HCl (pH 7.5), 0.5 M NaCl, 5 mM EDTA, and 1 ϫ 10 5 cpm of 32 P-end-labeled primer. After heating at 85°C for 5 min, the solution was incubated at 60°C for 1 h. The extension reaction was then initiated by adding a 40-l solution containing 12.5 mM TrisHCl (pH 8.3), 20 mM MgCl 2 , 12.5 mM DTT, 20 units of RNasin, 1.25 mM each of dNTP, and 10 units of avian myeloblastosis virus reverse transcriptase (Promega). After incubation for 1 h at 42°C, the reaction was stopped by adding 50 l of a solution containing 1% SDS and 20 mM NaCl. The reaction product was precipitated with 250 l of ethanol and loaded onto an 8% polyacrylamide-urea gel, and the results were analyzed by a phosphorimage analyzer (Fuji BAS 1000).
RESULTS

Functional Mapping of the Human CYP1B1
Promoter-A series of reporter plasmids containing the various CYP1B1 5Ј-flanking fragments (from nt Ϫ2300 to nt Ϫ164) in the sense orientation upstream to the CAT gene were transfected into SCC12(c12c2) cells (see "Experimental Procedures"). The level of CAT activity for each construct was normalized with respect to a co-transfected ␤-galactosidase plasmid and then compared with the negative control (promoterless plasmid).
The construct containing the longest 5Ј-flanking sequence (Ϫ2300/ϩ25) exhibited 43-fold greater CAT activity than the promoterless control (Fig. 1) . Removal of the region between Ϫ2300 and Ϫ1356 resulted in a 45% reduction of CAT activity. When the deletion was extended to nt Ϫ1022, a 2.5-fold increase in the activity was observed as compared with the construct with its 5Ј-end at nt Ϫ1356 (Fig. 1 ). This construct (Ϫ1022/ϩ25) showed the highest transcriptional activity (greater than 60-fold relative to the promoterless plasmid) of all the constructs tested. A further removal in sequence to nt Ϫ835 dramatically decreased the CAT activity by 90%. The promoter activity gradually increased with progressive 5Ј-deletions from nt Ϫ835, with the shortest promoter sequence (Ϫ164/ϩ25) possessing 33-fold greater activity than the promoterless control (Fig. 1) . The results of this initial 5Ј-deletion analysis indicate that the fully active CYP1B1 promoter is contained within the Ϫ164/ϩ25 fragment. The pattern of CAT activity for the various deletion constructs suggest that potential enhancer elements are located between nt Ϫ2300 and nt Ϫ1356 and between nt Ϫ1022 and Ϫ835. Potential negative regulatory elements are located between nt Ϫ1356 and Ϫ1022 and between nt Ϫ835 and Ϫ164 (Fig. 1) .
Based on sequence analysis, the Ϫ164/ϩ25 fragment contains a TATA-like box (TTAAAA) from nt Ϫ33 to Ϫ28, two Sp1 sites (GGGCGG) starting at nt Ϫ84 and Ϫ68 on the antisense strand, and a potential initiator element (TTGACTCT) from nt Ϫ3 to ϩ5. No known enhancer elements are located in the Ϫ164/ϩ25 fragment. To determine if these putative regulatory elements in the CYP1B1 promoter are functional, a series of 5Ј-deletion constructs within the Ϫ164/ϩ25 fragment were made (Fig. 2) . A deletion of 53 base pairs, from the 5Ј-end to nt Ϫ101, only slightly altered the promoter activity, indicating that the region from Ϫ164 to Ϫ101 does not contain any critical cis-acting element(s) that contribute(s) to promoter activity. Deletions that removed one or both Sp1 binding motifs reduced CAT activity by 80 -95%, respectively, from that observed with the Ϫ101/ϩ25 construct (Fig. 2) . The smallest 5Ј-flanking construct examined (Ϫ47/ϩ25), which contained both the TATAlike box (TTAAAA) and putative Inr (TTGACTCT), exhibited 2-4-fold greater CAT activity than the promoterless control ( Fig. 2) and is defined operationally as the basal promoter for CYP1B1. Full promoter activity requires both Sp1 motifs located within the Ϫ101/ϩ25 fragment. The CAT activity measured for constructs containing sequences 3Ј-ward from the TIS of the CYP1B1 gene was reduced relative to the Ϫ164/ϩ25 and Ϫ101/ϩ25 constructs (Fig. 2) . However, the longest 3-ward construct examined (Ϫ164/ϩ761) containing the first exon and intron of the CYP1B1 gene displayed 8-fold greater CAT activity than the basal promoter (Ϫ47/ϩ25).
Site-directed Mutagenesis of CYP1B1 Promoter ElementsMutations at the distal (nt Ϫ89 to Ϫ84) or proximal (nt Ϫ73 to nt Ϫ68) Sp1 binding motifs resulted in a 65% or 71% decrease, respectively, in CAT activity, as compared with the nonmutated (Ϫ164/ϩ25) construct (Fig. 3) . Mutations at both Sp1 sites reduced CAT activity to 20% of the fully active promoter. Mutating the TATA-like motif (TTAAAA) to TGCAGA or the putative initiator element from TTGACTCT to TTTCTAGA suppressed promoter activity by 85% or 55%, respectively (Fig.  3) . Taken together, these results indicate that all of the four regulatory elements identified by sequence analysis and deletion mapping (Fig. 2) are required for full CYP1B1 promoter activity.
Gel Shift Analysis of Sp1 Binding-Based on the mutational analysis supporting the involvement of both Sp1 sites for full promoter activity (Fig. 3) , a radiolabeled Ϫ101/Ϫ47 probe containing both Sp1 sites was prepared (see "Experimental Procedures") and incubated with nuclear extracts from SCC12(c12c2) cells. Two major complexes (shown by arrows) are observed, which co-migrate with complexes formed when the same probe is incubated with purified recombinant Sp1 protein (Fig. 4) . The addition of a 100-fold molar excess of unlabeled Ϫ101/Ϫ41 fragment competed with the labeled probe (Fig. 4, lane 6) , whereas little or no competition was observed with a nonspecific probe (Fig. 4, lane 7) or a probe containing double mutations in both Sp1 sites (Fig. 4, lane 8) . The same pattern of competition was observed with the purified Sp1 protein (data not shown). These results support the findings from site-directed mutagenesis (Fig. 3 ) and indicate the involvement of Sp1 in regulating the activity of the CYP1B1 promoter.
Analysis of the CYP1B1 Initiator Element-We have demonstrated previously that the transcription of the human CYP1B1 gene begins at a single site (7) . Based on sequence analysis, the CYP1B1 promoter does not contain a consensus TATA box, but does possess a potential Inr element from nt Ϫ3 to ϩ5. When the Inr sequence in the CYP1B1 promoter is aligned with other reported Inr elements, considerable sequence homology is observed ( Fig. 5 ): identical matches with 9 of 12 nucleotides in the Inr found in the TATA-less promoter of TdT between nt Ϫ3 to ϩ9 and with 5 of 8 nucleotides in the Ϫ3 to ϩ5 sequence of the AdML. FIG. 1. Identification of the CYP1B1 promoter. Top, schematic diagram of CYP1B1 gene including 5Ј-flanking region, introns, and exons. Bottom, a series of heterologous CAT reporter constructs were made that contained progressive deletions of the 5Ј-flanking regions of the CYP1B1 gene. These constructs were transfected into SCC12(c12c2) cells and CAT activities were assayed 24 h after transfection (see "Experimental Procedures"). The numbers shown next to the constructs represent the nucleotide positions relative to the TIS. The relative activity refers to the ratio of normalized CAT activity of each construct to that of the promoterless pCAT-Basic plasmid. Values are the average of two to three independent experiments performed in triplicate. Replicates within an experiment varied by less than 1%. Variability of normalized CAT activity between experiments was less than 10%.
FIG. 2.
Mapping the functional elements of the CYP1B1 promoter. Heterologous CYP1B1 CAT reporter constructs containing progressive 5Ј-end deletions from nucleotide Ϫ164 and constructs containing regions downstream from the TIS up to the first intron were assayed for CAT expression (see "Experimental Procedures"). The plasmid pCAT(Ϫ101/ϩ25), which contained four potential promoter regulatory elements initially identified by nucleotide sequence, displayed the highest CAT activity and was assigned a value of 100%. Values shown are relative to the pCAT(Ϫ101/ϩ25) plasmid and were determined in multiple samples as described in Fig. 1 .
To determine if the Inr in the CYP1B1 promoter is responsible for maintaining accuracy of transcription from a single site, we transcribed in vitro a Ϫ164/ϩ25 fragment containing the four CYP1B1 promoter regulatory elements (Fig. 3) , as well as promoter fragments with mutations in each element. The transcribed RNA was then analyzed by primer extension with a labeled downstream primer (Fig. 6) . A closely spaced doublet signal was observed with the nonmutated Ϫ164/ϩ25 fragment. This most likely represents a single band, with the doublet signal resulting from capping of the transcribed RNA. This same doublet signal was observed with the fragments containing mutations in one or both Sp1 sites, or in the TATA-like box. In contrast, multiple bands were observed when the Inr sequence was mutated (Fig. 6) . These results strongly support the position that the start site of transcription in the CYP1B1 promoter is determined by the Ϫ3 to ϩ5 Inr sequence (TTGACTCT).
Gel shift analysis was carried out to determine if proteins present in nuclear extracts from SCC12(c12c2) cells could bind specifically to the Inr in the CYP1B1 promoter. One major complex is observed when a radiolabeled probe containing the CYP1B1 Inr is incubated with nuclear extract proteins (Fig. 7) . Competition by a probe for the highly homologous murine TdT Inr competes with the CYP1B1 Inr for binding with nuclear extracts. Competition by a AdML Inr probe also is observed, but requires a higher concentration (400-fold) of unlabeled probe. Using a radiolabeled TdT Inr probe, a major DNAprotein complex was observed with SCC12(c12c2) nuclear extracts (Fig. 7) . Specific competition occurred with either unlabeled TdT Inr or CYP1B1 Inr probes, but not with the AdML Inr or a mutated CYP1B1 probe. These results suggest that the Inr regions for both TdT and CYP1B1 can recognize DNAbinding proteins in SCC12(c12c2) cells. The CYP1B1 Inr appears to be less specific than the TdT Inr, as indicated by the differential competition with unlabeled AdML Inr.
DISCUSSION
Stepwise deletion of the 5Ј-flanking region of the CYP1B1 gene indicated that the regions between nt Ϫ2300 and nt FIG. 3 . Site-directed mutagenesis of the functional elements located in the CYP1B1 promoter. The four regulatory elements (top) in the CYP1B1 promoter, two Sp1 motifs (rectangle), TATA-like box (oval), and an Inr motif (triangle), were specifically mutated and the mutant constructs assayed for CAT activity after transfection into SCC12(c12c2) cells (bottom). The CAT activity of the wild type (WT) construct with all four regulatory elements intact was assigned a value of 100%. Values shown were determined in multiple samples as described in Fig. 1.   FIG. 4 . Gel mobility shift assay of Sp1 binding. A DNA probe (from Ϫ101 to Ϫ43) containing both Sp1 sites was end-labeled and used to assay nuclear extracts for binding activity (see "Experimental Procedures"). Ϫ1356 and between nt Ϫ1022 and nt Ϫ835 may contain transcriptional enhancer elements (Fig. 1) . The Ϫ1022/Ϫ835 region has been shown previously to contain three dioxin-responsive core binding motifs that contribute to the TCDD-inducible expression of CYP1B1 (7) . Although cells were not treated with TCDD in this study, it is possible that the dioxin-responsive enhancers or other cis elements were responsive to components in the serum or medium, or to constitutively expressed cell proteins. In this regard, two repeats of the motif GGGTGG are located within the Ϫ1022/Ϫ835 region, with a third at Ϫ1061. Although this motif contains a T in place of the C in the consensus Sp1 binding site (GGGCGG; Ref. 23) , it has been demonstrated to bind the transcription factor Sp1 and activate a high level of transcription (24) . Sp1-dependent enhancer activity has been demonstrated for the human adenosine deaminase gene (25) , the rat ␣2MR/LRP gene (26) and ornithine decarboxylase (27) genes, and the SV40 enhancer (28) . Sp1 also can act synergistically with either the androgen (29), glucocorticoid (30), or epidermal growth factor (31) receptor to enhance gene expression.
Deletion mapping (Fig. 2) and site-directed mutagenesis (Fig. 3) have identified four regulatory elements that are required for maximum activity of the CYP1B1 promoter: two Sp1 binding motifs, a TATA-like sequence, and an Inr overlapping the TIS. Sp1 sites as far removed as 87 bp upstream from the TIS have been shown to be functional and to act in a bidirectional manner (32) . In this regard, both of the active Sp1 sites in the CYP1B1 promoter were located on the antisense strand at nt Ϫ68 and Ϫ84, respectively. These sites functioned in an additive manner to activate transcription.
The human CYP1B1 promoter does not contain a consensus TATA box (TATAAA) but, instead, a closely related TATA-like sequence (TTAAAA) at nt Ϫ34 (Fig. 3) . The transcription factor TFIID binds to sites in the nt Ϫ30 region of several promoters lacking consensus TATA boxes (33) (34) (35) (36) including the AT-rich elements (37) such as the ATAAAA sequence found in the bovine elastin gene (38) . For this group of TATA-less promoters, the level of transcriptional activity correlates with differences in the affinity of TFIID for binding to the nt Ϫ30 region (39) . By extension, it would be predicted that the TATA-like element of the CYP1B1 promoter, which is highly similar to the consensus TATA box sequence, would have a high affinity for TFIID and thus high promoter activity. This position is supported by the results shown in Fig. 3 . Mutation of the TATAlike element to TGCAGA decreased promoter activity by 75%.
The contribution of the Inr that overlaps the TIS to CYP1B1 promoter activity is less than either Sp1 sites or the TATA-like box (Fig. 3) . However, the in vitro transcription analysis carried out here (Fig. 6 ) strongly supports the position that the Inr is essential for maintaining fidelity of CYP1B1 transcription from a single site, as demonstrated previously (7) . Either a consensus TATA box or an initiator sequence is sufficient to direct the Sp1-dependent activated transcription from a single site (40, 41) . When a promoter contains both core elements, the TATA and Inr can act cooperatively to enhance the transcription levels and to assure the specificity of the start site. In the absence of a functional Inr, mutations in the TATA sequence can result in the initiation from multiple sites (42, 43) . Other studies on TATA-less promoters have suggested the involvement of Sp1 motifs in transcription start site selection (27, 44, 45) . Our data indicate that for the CYP1B1 promoter the Inr alone determines that transcription initiates from a single site, even in the absence of the upstream TATA counterpart (Fig. 6) . Similar results have been reported for three mouse ribosomal protein promoters (46) and for the Inr-containing adenovirus IVa2 and major late promoters (47, 48) . Mutation of the consensus TATA box in AdML and the TATA analog in Iva2 significantly decreased the transcriptional activity, but the position of the transcriptional start site was maintained.
A strict sequence conservation is missing in many of the known Inr elements. However, we found the CYP1B1 Inr is highly homologous to the TdT Inr (match of 9 of 12 nucleotides) and closely related to the AdML Inr beginning at nt Ϫ3 (Fig. 5) . Consistent with this observation based on nucleotide sequence, we found that DNA-binding proteins present in SCC12(c12c2) nuclear extracts can bind specifically to oligonucleotide probes for either the CYP1B1 or TdT Inr element (Fig. 7) . Further, nuclear extract protein binding to the CYP1B1 Inr probe was competed by either the TdT or AdML Inr probes. Thus, it is likely that the same or closely related nuclear proteins interact with the CYP1B1, TdT, and AdML Inr elements.
